Alaunos Therapeutics Director Vieser Acquires 6,515 Shares at $2.59

Jaime Vieser, a director of Alaunos Therapeutics, Inc. (TCRT), acquired 6,515 shares of common stock at $2.59 per share on April 29, 2026. The shares were issued in lieu of board fees. Following this transaction, Vieser directly holds 38,853 shares. Additionally, Vieser has indirect ownership through family members and entities: 2,100 shares held by his children and 13,503 shares held by Brushwood LLC, where Vieser serves as Manager. The total combined holdings amount to 54,456 shares across direct and indirect ownership structures. This Form 4 filing represents a routine disclosure of director stock compensation and ownership changes, showing the director's increased equity position in the company through board service compensation.